Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

Author： Sales MF   Sóter MO   Candido AL   Fernandes AP   Oliveira FR   Ferreira ACS   Sousa MO   Ferreira CN   Gomes KB  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.29, Iss.10, 2013-10, pp. : 936-939

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS

By Grubic N.   Stegnar M.   Peternel P.   Kaider A.   Binder B.R.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 431-443

Elsevier

Access to resources Recommend Favorite

4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Insertion/Deletion Polymorphism of the Tissue-Type Plasminogen Activator Gene in Atherothrombotic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 4, 2001-05 ,pp. : 294-299

Karger

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis

By Eroglu Aydan   Ulu Arzu   Akar Nejat  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 2, 2006-10 ,pp. : 111-112

Springer Publishing Company

Access to resources Recommend Favorite

4G/5G PAI-1 Promoter Polymorphism and Acute-Phase Levels of PAI-1 Following Coronary Bypass Surgery: A Prospective Study

By Burzotta Francesco   Iacoviello Licia   Di Castelnuovo Augusto   Zamparelli Roberto   D'Orazio Andria   Amore Concetta   Schiavello Rocco   Donati Maria Benedetta   Maseri Attilio   Possati GianFederico   Andreotti Felicita  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

By Lindholm Åsa   Bixo Marie   Eliasson Mats   Hudecova Miriam   Arnadottir Ragnheidur   Holte Jan   Poromaa Inger Sundström  

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite